Venaxis Inc news

   Watch this stock
Showing stories 1 - 10 of about 25   

Articles published

APPY 1.73 +0.02 (1.17%)
price chart
Venaxis to Present at Canaccord Genuity 34th Annual Growth Conference
CASTLE ROCK, Colo., Aug. 5, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1(TM) Test, a rapid, multi-analyte assay for aiding in identifying ...
Related articles »  
Venaxis to Present at September Investor Conferences
CASTLE ROCK, Colo., Aug. 28, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid blood test for aiding in identifying ...
Related articles »  
Venaxis Announces Regulatory and Market Development Progress
11, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1� Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and ...
FDA wants more details on Venaxis' new ER diagnostic technology  Denver Business Journal (blog)
Related articles »  
Venaxis to Provide Business Update, including FDA Submission Update
CASTLE ROCK, Colo., Aug. 7, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1� Test, a rapid, multi-analyte assay for aiding in identifying ...
Related articles »  
Morning Buzz: OXiGENE (NASDAQ:OXGN), Pluristem Therapeutics (NASDAQ ...
On 28 AUG Venaxis, Inc. (NASDAQ:APPY) announced it will present at three upcoming investor conferences: the Rodman & Renshaw 16(th) Annual Global Investment Conference being held in New York on September 8-10, 2014, the Aegis Capital 2014 ...
Today's Hot List: Sevcon, Inc. (NASDAQ:SEV), SanDisk Corp. (NASDAQ:SNDK ...
Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1(TM) Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and young adult patients that ...
Why Need to Watch: Cavium (NASDAQ:CAVM), Amgen (NASDAQ:AMGN ...
Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid blood test for aiding in identifying children, adolescent, and young adult patients in the ...
Related articles »  
Moving Stocks: ON Semiconductor Corp. (NASDAQ:ONNN), Revance ...
On 7 AUG Venaxis, Inc. (NASDAQ:APPY) announced it will provide a business update, including discussion on the progress of the APPY1 FDA submission, on Monday, August 11, 2014, at 8:30 a.m.
Traders Are Watching: Atmel (NASDAQ:ATML), BioDelivery Sciences ...
Venaxis, Inc. (NASDAQ:APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1� Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and young adult patients who ...
Related articles »  
Canaccord Genuity Group Inc - 1st Quarter Results
... for Venaxis, Inc. on the NASDAQ � In Canada, Canaccord Genuity participated in raising $342.8 million for government and corporate bond issuances during fiscal Q1/15 � Canaccord Genuity generated advisory revenues of $32.7 million during fiscal Q1 ...
Related articles »